Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA- Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Naga CHP, Gurram L, Chopra S, Mahantshetty U. The management of locally advanced cervical cancer. Curr Opin Oncol. 2018;30:323–9.

Article  Google Scholar 

Zheng R, Sun K, Zhang S, Zeng H, Zou X, Chen R, Gu X, Wei W, He J. Report of cancer epidemiology in China, 2015. Chin J Oncol. 2019;41:19–28.

CAS  Google Scholar 

Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obstet. 2021;155:28–44.

Article  Google Scholar 

Zhang Q, Guo J, Ouyang H, Chen S, Zhao X, Yu X. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy. Eur Radiol. 2022;32:2529–39.

Article  PubMed  Google Scholar 

Jiang P, Kong W, Gong CX, Chen YL, Li FL, Xu LY, Yang Y, Gou SK, Hu ZY. Predicting the recurrence of operable cervical cancer patients based on hemoglobin, albumin, lymphocyte, and platelet (HALP) score and classical clinicopathological parameters br. J Inflamm Res. 2022;15:5265–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lucia F, Visvikis D, Desseroit MC, Miranda O, Malhaire JP, Robin P, Pradier O, Hatt M, Schick U. Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy. Eur J Nucl Med Mol I. 2018;45:768–86.

Article  Google Scholar 

Rose PG, Java J, Whitney CW, Stehman FB, Lanciano R, Thomas GM, DiSilvestro PA. Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable prognostic factors in patients from NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy. J Clin Oncol. 2015;33:2136–42.

Article  PubMed  PubMed Central  Google Scholar 

Freitas AC, Bocking A, Hill JE, Money DM, Grp VR. Increased richness and diversity of the vaginal microbiota and spontaneous preterm birth. Microbiome. 2018;6:117.

Article  PubMed  PubMed Central  Google Scholar 

Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. Vaginal microbiome of reproductive-age women. PNAS. 2011;108:4680–7.

Article  CAS  PubMed  Google Scholar 

Chee WJY, Chew SY, Than LTL. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Fact. 2020;19:203.

Article  PubMed  PubMed Central  Google Scholar 

Ruíz FO, Pascual L, Giordano W, Barberis L. Bacteriocins and other bioactive substances of probiotic lactobacilli as biological weapons against Neisseria gonorrhoeae. Pathogens Dis. 2015;73:ftv013.

Google Scholar 

Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG-Int J Obstet Gy. 2020;127:171–80.

Article  CAS  Google Scholar 

Zhou ZY, Tang WL, Ou JX, Li P, Ling YJ, Lv YL, Zhou HW, Chen MX. Vaginal dysbiosis dominated by miscellaneous bacteria correlates with more severe clinical symptoms. Infect Genet Evol. 2020;79:104138.

Article  CAS  PubMed  Google Scholar 

Qin HY, Jiao J, Disi A, Hua MX, Han K, Du HA, Wang Z, Li JR, Zhang D, Xiao BB, Chen C. Single-molecule approach to 16S rRNA for vaginal microbiome signatures in response to metronidazole treatment. Microbiol Spectr. 2023;11:e01706–22.

Article  PubMed  PubMed Central  Google Scholar 

Gajer P, Brotman RM, Bai GY, Sakamoto J, Schuette UME, Zhong X, Koenig SSK, Fu L, Ma ZSS, Zhou X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4:132ra52.

Article  PubMed  PubMed Central  Google Scholar 

Champer M, Wong AM, Champer J, Brito IL, Messer PW, Hou JY, Wright JD. The role of the vaginal microbiome in gynaecological cancer. BJOG-Int J Obstet Gy. 2018;125:309–15.

Article  CAS  Google Scholar 

Li JKM, Wang LL, Wong CYP, Chiu PKF, Teoh JYC, Kwok HSW, Leung SCH, Wong SH, Tsui SKW, Ng CF. A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy. Prostate Cancer P D. 2021;24:1063–72.

Article  CAS  Google Scholar 

Cong J, Zhang YG, Xue YD, Zhang CT, Xu MJ, Liu D, Zhang RY, Zhu H. A plot study: changes of intestinal microbiota of patients with non-small cell lung cancer in response to osimertinib therapy. Front Microbiol. 2020;11:583525.

Article  PubMed  PubMed Central  Google Scholar 

Ventin-Holmberg R, Eberl A, Saqib S, Korpela K, Virtanen S, Sipponen T, Salonen A, Saavalainen P, Nissilä E. Bacterial and fungal profiles as markers of infliximab drug response in inflammatory bowel disease. J Crohns Colitis. 2021;15:1019–31.

Article  PubMed  Google Scholar 

Ponziani FR, De Luca A, Picca A, Marzetti E, Petito V, Del Chierico F, Reddel S, Sterbini FP, Sanguinetti M, Putignani L, et al. Gut dsbiosis and fcal clprotectin pedict rsponse to imune ceckpoint inhibitors in patients with hepatocellular carcinoma. Hepatol Commun. 2022;6:1492–501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shaikh FY, White JR, Gills JJ, Hakozaki T, Richard C, Routy B, Okuma Y, Usyk M, Pandey A, Weber JS, et al. A uniform computational approach improved on existing pipelines to reveal microbiome biomarkers of nonresponse to immune checkpoint inhibitors. Clin Cancer Res. 2021;27:2571–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu XX, Rao HT, Fan XJ, Pang XW, Wang YC, Zhao LQ, Xing J, Lv XJ, Wang TZ, Tao J, et al. HPV-related cervical diseases: alteration of vaginal microbiotas and promising potential for diagnosis. J Med Virol. 2023;95:e28351.

Article  CAS  PubMed  Google Scholar 

Breiman L, Random, Forests. Mach Learn. 2001;45:5–32.

Article  Google Scholar 

Li HR, Wu XH, Cheng X. Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 2016;27:1–20.

Article  Google Scholar 

Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN, Gaffney DK. Cervical cancer: a global health crisis. Cancer. 2017;123:2404–12.

Article  PubMed  Google Scholar 

Vokes EE, Crawford J, Bogart J, Socinski MA, Clamon G, Green MR. Concurrent chemoradiotherapy for unresectable stage III non-mall cell lung cancer. Clin Cancer Res. 2005;11:s5045–50.

Article  Google Scholar 

Yang H, Liu H, Chen YP, Zhu CC, Fang WT, Yu ZT, Mao WM, Xiang JQ, Han YT, Chen ZJ, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36:2796.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Z, Xiao R, Huang J, Qin X, Hu D, Guo E, Liu C, Lu F, You L, Sun C, Chen G. The diversity of vaginal microbiota predicts neoadjuvant chemotherapy responsiveness in locally advanced cervical cancer. Microb Ecol. 2022;84:302–13.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381:1124–35.

Article  CAS  PubMed  Google Scholar 

Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ, Ma J. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol. 2011;80:661–8.

Article  Google Scholar 

Lee AWM, Ng WT, Chan LLK, Hung WM, Chan CCC, Sze HCK, Chan OSH, Chang ATY, Yeung RMW. Evolution of treatment for nasopharyngeal cancer-success and setback in the intensity-modulated radiotherapy era. Radiother Oncol. 2014;110:377–84.

Article  PubMed  Google Scholar